KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Work In Process (2016 - 2019)

Historic Work In Process for NovoCure (NVCR) over the last 6 years, with Q2 2019 value amounting to $9.1 million.

  • NovoCure's Work In Process rose 7307.77% to $9.1 million in Q2 2019 from the same period last year, while for Jun 2019 it was $9.1 million, marking a year-over-year increase of 7307.77%. This contributed to the annual value of $8.7 million for FY2018, which is 275.04% up from last year.
  • As of Q2 2019, NovoCure's Work In Process stood at $9.1 million, which was up 7307.77% from $8.2 million recorded in Q1 2019.
  • In the past 5 years, NovoCure's Work In Process ranged from a high of $11.0 million in Q2 2017 and a low of $3.2 million during Q3 2015
  • Moreover, its 5-year median value for Work In Process was $8.2 million (2016), whereas its average is $7.5 million.
  • As far as peak fluctuations go, NovoCure's Work In Process skyrocketed by 26078.12% in 2015, and later plummeted by 5199.16% in 2018.
  • Over the past 5 years, NovoCure's Work In Process (Quarter) stood at $4.6 million in 2015, then skyrocketed by 79.56% to $8.3 million in 2016, then increased by 1.72% to $8.4 million in 2017, then rose by 2.75% to $8.7 million in 2018, then grew by 5.18% to $9.1 million in 2019.
  • Its Work In Process was $9.1 million in Q2 2019, compared to $8.2 million in Q1 2019 and $8.7 million in Q4 2018.